Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$15.7M Sell
420,500
-152,000
-27% -$6.38M 1.07% 39
2026
Q1
$28M Buy
572,500
+38,768
+7% +$2.03M 2.23% 22
2025
Q4
$28.3M Buy
533,732
+232
+0% +$13.5K 2.5% 19
2025
Q3
$32.7M Buy
533,500
+9,323
+2% +$537K 2.91% 13
2025
Q2
$27.9M Buy
524,177
+3,177
+0.6% +$136K 2.73% 14
2025
Q1
$18.5M Buy
521,000
+96,000
+23% +$3.56M 2.15% 22
2024
Q4
$14.8M Buy
+425,000
New +$15M 1.65% 26

Other funds holding CALX

Harvey Partners's CALX Position: Q2 2026 in Review

Harvey Partners reduced its Calix (CALX) stake by 27% in Q2 2026, selling an estimated $6.38M and leaving 420,500 shares worth $15.7M. The position accounts for 1.07% of the portfolio, ranked #39.

Harvey Partners first reported a position in CALX in Q4 2024 and has held it in 7 quarters since. The position peaked at $32.7M in Q3 2025. 287 funds tracked by Wall St. Rank hold CALX as of Q2 2026.

  • Harvey Partners held 420,500 shares of Calix worth $15.7M as of Q2 2026.
  • Harvey Partners sold 152,000 Calix shares in Q2 2026, an estimated $6.38M.
  • Calix made up 1.07% of Harvey Partners's portfolio in Q2 2026, its #39 holding.
  • Harvey Partners first reported a position in Calix in Q4 2024 and has held it in 7 quarters since.
  • Harvey Partners's Calix position peaked at $32.7M in Q3 2025.
  • 287 funds tracked by Wall St. Rank held Calix as of Q2 2026.

Based on Harvey Partners's 13F filing for Q2 2026, filed 14 Aug 2026.